Overview

Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
A study of subjects with a known nickel allergy comparing Tacrolimus to placebo, both associated with nickel patches to determine the safety and efficacy of treating Chronic Allergic Contact Dermatitis with Tacrolimus Ointment
Phase:
Phase 4
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Tacrolimus